Gabelli Funds LLC Novartis Ag Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Novartis Ag stock. As of the latest transaction made, Gabelli Funds LLC holds 84,500 shares of NVS stock, worth $8.32 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

84,500

Previous 85,000 0.59%

Holding current value

$8.32 Million

Previous $9.05 Million 7.4%

% of portfolio

0.08%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $53,065 - $60,445	-500 Reduced 0.59%	84,500 $9.72 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $92,570 - $107,370	-1,000 Reduced 1.16%	85,000 $9.05 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $95,270 - $108,470	-1,000 Reduced 1.15%	86,000 $8.32 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $230,675 - $253,850	-2,500 Reduced 2.79%	87,000 $8.78 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $201,300 - $234,375	-2,500 Reduced 2.72%	89,500 $7.57 Million
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $79,700 - $88,130	-1,000 Reduced 1.08%	92,000 $8.05 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $170,480 - $188,300	-2,000 Reduced 2.11%	93,000 $8.49 Million
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $83,500 - $98,470	-1,000 Reduced 1.04%	95,000 $8.12 Million
Q4 2020 Feb 05, 2021	SELL	$78.07 - $94.43 $234,209 - $283,290	-3,000 Reduced 3.03%	96,000 $9.07 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $84,350 - $95,370	-1,000 Reduced 1.0%	99,000 $9.37 Million
Q2 2019 Aug 02, 2019	SELL	$75.4 - $92.8 $678,600 - $835,200	-9,000 Reduced 8.26%	100,000 $9.13 Million
Q1 2019 May 02, 2019	SELL	$75.32 - $86.15 $1.51 Million - $1.72 Million	-20,000 Reduced 15.5%	109,000 $10.5 Million
Q4 2018 Jan 30, 2019	SELL	$73.66 - $82.02 $5.82 Million - $6.48 Million	-79,000 Reduced 37.98%	129,000 $11.1 Million
Q3 2018 Nov 02, 2018	SELL	$66.94 - $77.43 $267,760 - $309,720	-4,000 Reduced 1.89%	208,000 $17.9 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $3.38 Million - $3.81 Million	-52,000 Reduced 19.7%	212,000 $16 Million
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $1.65 Million - $1.98 Million	-23,500 Reduced 8.17%	264,000 $21.3 Million
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $108,495 - $116,460	-1,500 Reduced 0.52%	287,500 $24.1 Million
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $21.4 Million - $22.3 Million	289,000	289,000 $24.8 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Novartis Ag Transaction History